These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 17512927

  • 1. Curative-like analgesia in a neuropathic pain model: parametric analysis of the dose and the duration of treatment with a high-efficacy 5-HT(1A) receptor agonist.
    Deseure K, Bréand S, Colpaert FC.
    Eur J Pharmacol; 2007 Jul 30; 568(1-3):134-41. PubMed ID: 17512927
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. High-efficacy 5-HT1A receptor activation causes a curative-like action on allodynia in rats with spinal cord injury.
    Colpaert FC, Wu WP, Hao JX, Royer I, Sautel F, Wiesenfeld-Hallin Z, Xu XJ.
    Eur J Pharmacol; 2004 Aug 16; 497(1):29-33. PubMed ID: 15321732
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. 5-HT(1A) receptor activation: new molecular and neuroadaptive mechanisms of pain relief.
    Colpaert FC.
    Curr Opin Investig Drugs; 2006 Jan 16; 7(1):40-7. PubMed ID: 16425670
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The novel analgesic, F 13640, produces intra- and postoperative analgesia in a rat model of surgical pain.
    Kiss I, Degryse AD, Bardin L, Gomez de Segura IA, Colpaert FC.
    Eur J Pharmacol; 2005 Oct 31; 523(1-3):29-39. PubMed ID: 16226246
    [Abstract] [Full Text] [Related]

  • 9. The counteraction of opioid-induced ventilatory depression by the serotonin 1A-agonist 8-OH-DPAT does not antagonize antinociception in rats in situ and in vivo.
    Guenther U, Manzke T, Wrigge H, Dutschmann M, Zinserling J, Putensen C, Hoeft A.
    Anesth Analg; 2009 Apr 31; 108(4):1169-76. PubMed ID: 19299781
    [Abstract] [Full Text] [Related]

  • 10. Tolerance and inverse tolerance to the hyperalgesic and analgesic actions, respectively, of the novel analgesic, F 13640.
    Bruins Slot LA, Koek W, Tarayre JP, Colpaert FC.
    Eur J Pharmacol; 2003 Apr 18; 466(3):271-9. PubMed ID: 12694810
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacological properties of 3-amino-5,6,7,8-tetrahydro-2-[4-[4-(quinolin-2-yl)piperazin-1-yl]butyl]quinazolin-4(3H)-one (TZB-30878), a novel therapeutic agent for diarrhea-predominant irritable bowel syndrome (IBS) and its effects on an experimental IBS model.
    Tamaoki S, Yamauchi Y, Nakano Y, Sakano S, Asagarasu A, Sato M.
    J Pharmacol Exp Ther; 2007 Sep 18; 322(3):1315-23. PubMed ID: 17540858
    [Abstract] [Full Text] [Related]

  • 14. The novel analgesic and high-efficacy 5-HT1A receptor agonist F 13640 inhibits nociceptive responses, wind-up, and after-discharges in spinal neurons and withdrawal reflexes.
    You HJ, Colpaert FC, Arendt-Nielsen L.
    Exp Neurol; 2005 Jan 18; 191(1):174-83. PubMed ID: 15589524
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Chronic buspirone treatment normalizes open field behavior in olfactory bulbectomized rats: assessment with a quantitative autoradiographic evaluation of the 5-HT1A binding sites.
    Sato H, Skelin I, Debonnel G, Diksic M.
    Brain Res Bull; 2008 Mar 28; 75(5):545-55. PubMed ID: 18355630
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The selective 5-hydroxytryptamine 1A antagonist, AZD7371 [3(R)-(N,N-dicyclobutylamino)-8-fluoro-3,4-dihydro-2H-1-benzopyran-5-carboxamide (R,R)-tartrate monohydrate] (robalzotan tartrate monohydrate), inhibits visceral pain-related visceromotor, but not autonomic cardiovascular, responses to colorectal distension in rats.
    Lindström E, Ravnefjord A, Brusberg M, Hjorth S, Larsson H, Martinez V.
    J Pharmacol Exp Ther; 2009 Jun 28; 329(3):1048-55. PubMed ID: 19325032
    [Abstract] [Full Text] [Related]

  • 19. Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia.
    Muñoz A, Li Q, Gardoni F, Marcello E, Qin C, Carlsson T, Kirik D, Di Luca M, Björklund A, Bezard E, Carta M.
    Brain; 2008 Dec 28; 131(Pt 12):3380-94. PubMed ID: 18952677
    [Abstract] [Full Text] [Related]

  • 20. Mutant 5-hydroxytryptamine 1A receptor D116A is a receptor activated solely by synthetic ligands with a rich pharmacology.
    Cussac D, Palmier C, Finana F, De Vries L, Tardif S, Léger C, Bernois S, Heusler P.
    J Pharmacol Exp Ther; 2009 Oct 28; 331(1):222-33. PubMed ID: 19605522
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.